Brief: Tarsus Pharmaceuticals Inc Says FDA Discussion Planned For 2024 For TP-03
11/12/2023 13:45
Dec 11 (Reuters) - Tarsus Pharmaceuticals Inc TARS.O :
* TARSUS PHARMACEUTICALS INC- FDA DISCUSSION PLANNED FOR
2024 FOR
TP-03
Further company coverage: TARS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Tarsus Pharmaceuticals
See all newsBrief: Lisata Therapeutics Appoints Jeff Farrow To Board Of Directors
Brief: Tarsus Pharmaceuticals Files For Offering Of Up To 2.91 Million Shares Of Common Stock By Selling Stockholders
U.S. RESEARCH ROUNDUP-Argan, Mastec, Oracle
Tarsus Pharmaceuticals, Inc. reports results for the quarter ended June 30 - Earnings Summary
Tarsus to expand eye disease pipeline with up to $800 million Alkeus acquisition (updated)